Due to the ongoing Coronavirus pandemic, examinations may be replaced by an alternative form of assessment during the academic year 2020/2021. Please refer to the Programme Specification on these pages for further details.
About the course
The MSc Pharmacovigilance is a course developed by the School of Life and Medical Sciences at the University and the Pharmaceutical Information and Pharmacovigilance Association (PIPA). On this course you will study relevant techniques used in pharmacovigilance including the basis of adverse drug reactions, regulations and guidelines (UK, EU and major worldwide regions), handling safety issues including Labelling and Risk Management Systems and processes (both pre and post-marketing).
Why choose this course?
- Expertise of the staff, who are experienced professionals and have real world expertis in pharmacovigilance from the pharmaceutical industry and regulatory authorities
- Flexibility of study, based on intensive three-day taught courses with independent
- Pre and post coursework activities
- Practical research projects based on real-world situations
- Opportunities for sharing experiences and networking which contributes to the
What will I study?
Taught modules normally consist of approximately 24 hours class contact. In addition, about 120 hours will be needed to complete the pre and post-course activities. The actual amount of time spent will depend upon your existing knowledge and ability. All modules are free-standing. Satisfactory completion of four modules is compulsory for the PgCert; all eight modules are required for the PgDip and MSc. Coursework will contribute significantly to assessment and may comprise some or all of the following: summaries of pre-course reading, written reports of class discussions, essays, performances in seminars, poster presentations, problem solving or data interpretation exercise, short projects and case studies. Unseen written examinations will feature in some courses; they may be used to examine understanding of pre-course reading material. Attendance at the taught component and satisfactory completion of both coursework and examinations (where present), with a minimum mark of 50% in each element, is normally required to pass each module.
This course is accreditated by the PIPA (Pharmaceutical Information and Pharmacovigilance Association)
Potential candidates will normally be in either full or part-time employment and are likely to have a spread of responsibilities, mostly in pharmacovigilance and medical information, monitoring safety data in either pre- and post-marketing studies or from spontaneous reports. They will be graduates and/or experienced personnel and usually will have held positions in drug safety for one to several years. Some applicants may have doctorates and may be medically qualified. Following successful completion of the course the knowledge gained should enable the post-graduates to make a greater contribution to the pharmacovigilance industry.
Please note that some of the images and videos on our course pages may have been taken before social distancing rules in the UK came into force.